Introduction
Hypertension resistance to both volume control and drugs has been shown in a subgroup of patients, Guidelines should be used for clinical decisions about although it remains debatable whether 'dry weight' individual patients. However, most of the available was really achieved in all of these patients [4, 5] . guidelines are based on randomized clinical trials which only provide a statistical prediction of the likely effect of an intervention, usually based on the 'average' Effect of hypertension on survival outcome, aggregated across all the heterogeneous patients participating in the trial. Heterogeneity due to The well established concept that hypertension is a the stage of the disease, its severity, organ complica-risk factor for death both in the general population tion, comorbid conditions etc., together with exclusion and in dialysis patients has recently been questioned of the patients with major complications from the trial, by independent studies [4] [5] [6] [7] [8] [9] showing that low prelimit the information generated by such trials for a dialysis systolic BP is associated with increased precise prediction of outcome for an individual patient. adjusted mortality risk. No association with elevated Although these limitations may be partially circum-mortality risk has been observed for pre-dialysis sysvented by the clinical experience and pathophysiolog-tolic hypertension. A number of explanations may be ical knowledge of clinicians or experts (in the case of offered for this rather unexpected finding: (i) it may a guideline), personal bias is almost inevitable. A be an iatrogenic effect due to overmedication; (ii) all comprehensive approach to the issue of hypertension the studies were carried out in the USA on patients has recently been published [1] . The present review with an overall poor prognosis. The influence of summarizes the most important aspects discussed in expected survival is indeed crucial. The beneficial effect that review and, in particular, addresses some specific of BP reduction may need several years to become topics whcih, in the opinion of the Medical Expert visible, and this may not be detectable if life expectancy Group, are rather relevant.
is only 2-3 years; (iii) older malnourished patients have lower BP and shorter survival; and (iv) the presence of overt or not fully developed heart failure Prevalence or disease may lower BP and survival. The Cox proportional hazard used in some of these studies may be The prevalence of hypertension varies according to the inadequate to correct for all these confounding factors. degree and the cause of renal failure in chronic renal insufficiency (CRI ) or according to the type of dialytic treatment, haemodialysis ( HD) or peritoneal dialysis Pathophysiological basis for management (PD) . However, the prevalence of hypertension is much greater in the CRI population (60-100%) than in the In these clinical conditions, it is still not known if general population. With the remarkable exception of hypertension is caused by inappropriate secretion of Tassin, France, where >90% of patients achieve norm-renin for the status of body sodium and water, or if otension without anti-hypertensive medication [2] , the other renal or extra-renal factors are involved. A control of hypertension in HD patients is rather poor correct answer to this question is crucial not only for despite administration of anti-hypertensive drugs. This the understanding of the pathogenesis of hypertension poor control has also been documented with 24 h but also for a correct therapeutical approach. ambulatory blood pressure (BP) monitoring where a There are close interrelationships among the various feedback loops regulating BP (renal, hormonal, haemoCorrespondence and offprint requests to: Professor G. Bianchi, dynamic, neural and humoral ) [10] , so a change in Such secondary changes are likely to be controlled sion may rule out the importance of many extra-renal simply by normalizing the primary change that is mechanisms and suggests that one should concentrate responsible for the shift in the set point of the overall on renal mechanisms. Some years ago, when bilateral system. nephrectomy in HD or PD patients was more frequent, An example of this mechanism may be the increase this issue was reviewed [13] and it was concluded that, in plasma catecholamines after renal artery constriction in all cases where volume dependency could be or the increase in sympathetic activity which may occur assessed, hypertension was caused by an excess of in CRI [11] . Both events may contribute to the rise in sodium and water. This conclusion is so important BP. Experimentally, the increase in plasma catecholam-that it would be appropriate to have more data to ines is corrected by removing the primary cause (renal support it. artery constriction), which also normalizes body sodium and renin. Similarly, the sympathetic hyperEffect of kidney transplantation on BP activity of CRI may be corrected by administration of an angiotensin-converting enzyme (ACE) inhibitor [11] . Conversely, the blockade of the effect of catechol-Transplant hypertension may be a very relevant clinical amines at their receptor may correct some haemo-problem particularly when patients are given cyclospodynamic abnormalities but will not affect the primary rin, because of the well documented pressor effect of renal abnormalities responsible for the overall clinical this drug. Besides the mechanism discussed above and conditions. The well documented beneficial effects of below, a genetic factor must also be considered here. inhibitors of the renin-angiotensin system (RAS ) It has been shown that some hypertension can be (mainly ACE inhibitors) on both the cardiovascular transplanted with the kidney, both in rats and in system and the progression of renal failure may be due humans. In rats, this conclusion was reached with to their ability to block one of the primary triggering kidney cross-transplantation between genetically mechanisms responsible for the secondary cascade of hypertensive strains of rats and their normotensive events leading to the different clinical manifestations counterpart [14] . In humans, it was shown that recipiof the disease. This interpretation is weakened by the ents of kidneys removed from donors with hypertensive lack of careful studies comparing the long-term effects parents require more anti-hypertensive therapy to conof ACE inhibitors with that of blockers of the sympath-trol their BP than recipients of kidneys removed from etic system. The latter may be useful at least for donors with normotensive parents. This 'donor effect' controlling the symptoms and cardiac consequences of was seen only in recipients with normotensive parents hypertension, mainly in a subgroup of patients where and not in recipients with hypertensive parents, imply-ACE inhibitors, alone or in combination with calcium ing genetic co-adaptation and other genetic factors antagonists or a diuretic, cannot normalize BP.
[15]. Whatever the interpretation of these findings may The following points are relevant both for correct be, these data clearly support the relevance of genetic understanding of the pathogenetic mechanisms of factors in determining the level of BP in chronic renal hypertension in CRI or dialysis patients and for appro-failure or end-stage renal disease. priate therapeutic approaches:
Stage-or phase-dependency of the renal HD and PD mechanisms of hypertension
The prevalence of hypertension in PD patients is lower Experimental data on renovascular hypertension than that in HD patients, at least in the first years of clearly show that the pathogenetic mechanisms of treatment, although not all authors agree [16, 17] . hypertension and the BP response to drugs change Achievement of 'dry weight' is more successful in PD with time after the onset of renal artery stenosis [12] . patients, maybe because of the larger residual diuresis In the initial stages, the pressor effect of renin and the in PD patients or more favourable clearance of various efficiency of renin inhibitors on BP control are much humoral pressor factors. The more efficient rate of greater than in later stages of hypertension. This time-removal of sodium and water in PD than in HD may dependency of pressor mechanisms has also been also play a role. The different prevalence of hypertendemonstrated in human hypertension. The pressor sion tends to disappear with longer duration of PD, mechanisms at work in a patient with long-lasting which is also associated with the disappearance of renal disease thus differ from those in patients with a residual diuresis. The latter event contributes to a more renal disease of recent onset. Such a difference must difficult control of body fluids in those patients on be taken into account in the discussion of pathogenetic long-term PD than in those on short-term PD. or therapeutic issues.
BP control in long and short HD treatment and the Mechanisms of hypertension in anephric HD or PD lag phenomenon patients
Compared with short (3-4 h) HD, long (8 h) HD is The demonstration that anephric patients on HD or PD only have a sodium-/volume-dependent hyperten-associated with less cardiovascular morbidity (includHypertension in chronic renal failure 107 ing hypertension) and longer patient survival [18, 19] . evidence that, in the long run, the normalization of It has been suggested that the beneficial effect on BP body sodium and fluids achieved and maintained with may not be directly dependent on volume control since relatively low rates of fluid removal with long dialysis, normotensive patients on long HD may have the same as practised in Tassin, is sufficient to control BP volume indexes as hypertensive patients on short HD without antihypertensive drugs. The rate of fluid [20] . Unfortunately, many confounding factors were removal is probably also crucial: below a certain critical not properly controlled: diet, type of HD or lifestyle rate, the body's homeostatic feedback loop can adapt (French, Swedish, British and Dutch). These observa-much better, thus facilitating the achievement of the tions need to be confirmed by another better controlled 'normal' set point of body sodium, water and BP study, but suggest that long HD may achieve better existing before renal disease, without triggering counremoval of some vasoactive substance(s) that poten-ter-regulatory mechanisms. tially contribute to hypertension.
Failure to understand these phenomena may generBefore accepting this explanation, however, one ate a lot of confusion and unfruitful controversies. For must also consider the 'lag phenomenon' [18], i.e. the instance, acute studies [23] demonstrated a poor corfinding that the fall in BP is delayed with respect to relation between interdialytic BP changes and body the normalization of extracellular fluid volume. This weight changes (as an expression of acute change in lag phenomenon not only becomes apparent when body fluids). This finding has been used as an argument body fluid volume (or body weight) is plotted against against a relevant role of body fluids in BP regulation BP during the first months of dialysis, but is also and in favour of a role of other factors such as present in different clinical conditions involving reduc-sympathetic overactivity, nitric oxide, etc. [23] . tion of body sodium, such as when a very low sodium However, considering both the lag phenomenon and diet is started in patients with essential hypertension the time dependency of the pressor mechanism includor when patients with primary hyperaldosteronism are ing structural adaptation of vessels, this poor correlagiven aldosterone receptor antagonists. In both condi-tion with acute changes is not unexpected and cannot tions the normalization of body fluids precedes the be used as an argument against the long-term pressor decrease in BP. It is likely that this lag phenomenon role of body fluids. In other words, the variety of is increased in patients with long-lasting hypertension pressor mechanisms should not be considered only as where the structural modifications of the cardiovas-an expression of contrasting views on the pathogenesis cular system are more severe. This phenomenon is also of hypertension but also as an expression of the consistent with the time-dependency of the pressor sequence of pathophysiological feedback loops, which mechanisms, which was mentioned above in relation come into play in the different phases of the disease. to experimental renal hypertension.
This sequence is also affected by the overall genetic A precise cause-effect relationship among the and environmental background, modulating the hetdifferent pressor mechanisms triggered by decreased erogeneous pattern of organ complications or comorrenal function has not yet been established, although bid conditions affecting the individual patients. this sequence can be accepted as an established fact, A correct definition of the role of the individual at least in experimental renovascular hypertension.
pressor mechanisms present in a given patient must Soon after renal artery constriction, the increase in include the concept of context dependency. That is, plasma renin and peripheral vascular resistance the phase, time, genetics (if possible), environment, accounts for the concomitant BP increase only for a and so on, must be considered when assessing the few days. Later, body fluid retention contributes to respective role of each individual pressor mechanism. the hypertension by increasing plasma and extracellular Taking into consideration this concept of context fluid volume and cardiac output. A few weeks later, dependency, sodium and water retention together with plasma renin, body fluid and cardiac output are back inappropriate production of renin still have a leading to normal and hypertension is associated with increased role in determining BP. Therefore, all manoeuvres vascular resistance [21, 22] . Sympathetic hyperactivity, aimed at reducing and/or normalizing body sodium or increased plasma catecholamines, ouabain-like and water and the pressor effect of renin should rank factor (OLF ), endothelial factors and vascular strucfirst in the therapy of hypertension associated with tural changes (and/or peripheral autoregulatory mechrenal diseases or with dialysis. Patience must be allowed anisms of blood-flow adaptation) have all been before evaluating the effect on BP of such a manoeuvre. suggested as mechanisms supporting this third phase During the fundamental manoeuvres aimed at of hypertension. But the fundamental finding is that, achieving 'dry weight' in some patients, it may be if renal artery stenosis is removed within a critical helpful to add hypertensive agents (mainly inhibitors period of time, BP returns to normal. BP does not of the RAS or of the sympathetic system) temporarily, return to normal if the removal of renal artery stenosis which may accelerate the process of BP normalization. is carried out after that critical period of time. Some
In addition, it is not possible to exclude the possibility of the secondary pressor mechanisms mentioned above that the still functioning diseased kidney may, in some may therefore become autonomous, independent of patients, directly activate the sympathetic nervous the primary mechanisms that triggered them. The lag system. Drugs acting on the sympathetic nervous phenomenon, which also reflects all these mechanisms with the provisos above mentioned, may be taken as system may be required for this specific reason.
artery lesions are probably present in such patients, Diagnosis but has not yet been proven.
From the practical point of view, any patient with Renal artery disease has recently come to be regarded mild to moderate CRI who starts treatment with ACE as a common and increasingly frequent cause of CRI inhibitor should have his/her plasma creatinine mon- [24, 25] . Improvement of diagnostic procedures and itored for at least 14 days after initiation of therapy. ageing of the population with vessel alteration secondAn initial increase in plasma creatinine of ∏20-30% ary to atherosclerosis or diabetes may be responsible of the initial level is acceptable, but if plasma creatinine for such a phenomenon. Therefore, any evaluation of continues to rise above this critical level, ACE inhibpatients aged >50 years with hypertension and renal itors should be withdrawn. Two weeks of monitoring failure should at least include an echo Doppler study creatinine closely should be long enough to detect of the renal vascular tree.
initial impairment of renal function [31] . Creatinine Patients with hypertension, renal failure and other should then be measured twice monthly for 2 months, signs of peripheral artery disease should undergo an then every 2 months thereafter. angio magnetic resonance of the renal vessels, since
The critical serum creatinine above which ACE they have a high risk of renal artery disease (around inhibitors should not be given or should be stopped is 30-40%) and are potentially treatable. also controversial. Serum creatinine concentrations of 3 and 5 mg/dl, respectively, may be appropriate cut-
Treatment of hypertension
off levels. In patients who are already being treated with ACE inhibitors and in whom the withdrawal of these drugs does not produce a significant decrease in The most recent guidelines and publications [26, 27] recommend that the systolic and diastolic BP of plasma creatinine (>20%) within 1 month, the ACE inhibitor may be re-administered because these inhibpatients with CRI should be maintained at ∏130 mm Hg and ∏80 mm Hg for BP, respectively. When pro-itors have a recognized protective effect on the cardiovascular system. teinuria is present, the target BP should be reduced to ∏125/75 mm Hg. Adequate control of BP certainly ACE inhibitors are the first-choice drugs for treating hypertension in these clinical conditions. However, slows the progression of CRI and this effect is particularly evident in patients with increased urine protein they may not be able to normalize BP, may cause unacceptable impairment of renal function and may excretion. Such a beneficial effect was first demonstrated in diabetic nephropathy but has also been have side effects such as cough, angio-oedema, hyperkalaemia and anaemia. If this occurs, calcium-channel proven in other forms of nephropathy. There is a general agreement on the importance of reducing diet-blockers or angiotensin II receptor antagonists may be used instead of, or in combination with, ACE inhibitors ary sodium intake in these patients to about 2-3 g/day, and to use loop diuretics alone or in combination with to achieve target BP. There are data supporting the view that angiotensin II receptor antagonists, besides a thiazide diuretic if oedema refractory to loop diuretics is present.
their indication for patients in whom ACE inhibitors cause intolerable side effects, potentiate the hypotensive For some time, it has been debated whether certain classes of antihypertensive agents, independent of their effect of ACE inhibitors [32] .
Comorbid conditions such as coronary artery disantihypertensive effect, exert a beneficial effect on the preservation of renal function in CRI. Although this ease, tachyarrhythmias and prostate hypertrophy may require other drugs which may act on both hypertenquestion is not yet settled completely, this additional effect can be tentatively assigned to ACE inhibitors sion and the comorbid condition itself, e.g. b-blockers for arrhythmias or coronary artery disease, or a-blockers [28, 29] , while more studies are needed for the nondihydropyridine calcium antagonists or angiotensin II for presence of prostate hypertrophy. a-Methyl-dopa or clonidine may be needed in some patients when the receptor antagonists. The superiority of one ACE inhibitor over the others has not yet been demon-above drugs are unable to control the hypertension or produce severe side effects. The sympathetic hyperstrated [30] .
An important practical problem is the initial impair-activity present in some of these patients may provide the rationale for using these drugs when ACE inhibitors ment of renal function that occurs when therapy with ACE inhibitors is started in patients with CRI. The are inactive. magnitude of such an effect may vary from one patient to another. While the cause of such a decrease in Future directions in HD patients glomerular filtration rate (GFR) is clear (relative decrease in glomerular capillary pressure due to vasodilatation of the efferent arteriole), the cause of indi-At present the control of BP, particularly in patients on short (3-4 h) HD, is very poor, in spite of the vidual variation in the fall in GFR is less clear. Certainly, the presence of renal artery disease, particu-availability of very effective anti-hypertensive drugs [33] . In contrast, hypertension is almost absent in larly when bilateral, is one important cause that precludes the use of these drugs. However, a remarkable patients on long (8 h) HD. Long HD treatment is considerably more expensive and is not preferred by decrease of GFR may also occur in patients without renal artery disease. Some type of intrarenal small many patients, so it would be preferable to achieve the relationship to 2-years survival? Nephrol Dial Transplant 1999; same results of long dialysis by modifying the present 14: 125-128 short dialysis in hypertensive patients [34] . 
